Skip to content

Clinical trials

Completed Phase 1/2 Schizophrenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 1/2 Status: Completed Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20042
20051
20062
20071
20081
20092
20101
20112
20122
20131
20144
20161
20183
20193
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
New York State Psychiatric Institute2
Novartis Pharmaceuticals2
University of California, San Francisco2
Delpor, Inc.1
Douglas Mental Health University Institute1
Heinrich-Heine University, Duesseldorf1
Janssen Pharmaceutical K.K.1
Laval University1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia33
Psychotic Disorders12
Anxiety Disorders1
Bipolar Disorder1
Hallucinations1
Insulin Resistance1
Marijuana Abuse1
Obesity1
Tardive Dyskinesia1
Tobacco Use Disorder1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.